Department of Surgery, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
Gen Thorac Cardiovasc Surg. 2021 Jun;69(6):943-949. doi: 10.1007/s11748-020-01559-0. Epub 2021 Jan 1.
We classified pathological stage I invasive lung adenocarcinomas according to our 3-tier classification, which was based on the proportion of invasive morphological patterns as follows: (1) patients with each predominant subtype, (2) those with a minor histological subtype, even not the predominant subtype and (3) those without each invasive component. We aimed to evaluate the classification's clinical impact in survival, recurrence, malignant grade, and epidermal growth factor receptor (EGFR) mutational status.
A total of 1,269 patients with p-stage I lung adenocarcinoma underwent curative surgical resection between January 2008 and December 2017. Of these, 620 patients (48.9%) met the inclusion criteria of this study.
Postoperative recurrence was observed in 81 patients (13.1%). Multivariate analysis showed that vascular invasion (hazard ratio, 2.61; p < 0.001) and p-stage IB (hazard ratio, 2.19; p = 0.001) were significantly associated with an unfavorable RFS, while the presence of acinar component (hazard ratio, 1.64; p = 0.052) or solid component (hazard ratio, 1.60; p = 0.074) were marginally significant. The presence of lepidic or papillary component and the absence of acinar or solid component significantly correlated with an increased proportion of lung adenocarcinomas harboring EGFR mutations.
In patients with p-stage I invasive lung adenocarcinoma, it is beneficial to use not only the predominant subtype but analyzing the extent of each histological component based on our classification to predict patient prognoses and form appropriate postoperative follow-up methods.
我们根据三分类法对病理 I 期浸润性肺腺癌进行分类,该分类基于以下浸润形态模式比例:(1)主要亚型患者,(2)次要组织学亚型患者,甚至非主要亚型患者,(3)无任何浸润成分患者。我们旨在评估该分类对生存、复发、恶性程度和表皮生长因子受体(EGFR)突变状态的临床影响。
2008 年 1 月至 2017 年 12 月期间,共有 1269 例 p 期 I 期肺腺癌患者接受根治性手术切除。其中,620 例(48.9%)符合本研究的纳入标准。
81 例(13.1%)患者术后复发。多变量分析显示,血管侵犯(危险比,2.61;p<0.001)和 p 期 IB(危险比,2.19;p=0.001)与不良 RFS 显著相关,而腺泡成分(危险比,1.64;p=0.052)或实体成分(危险比,1.60;p=0.074)存在具有边缘意义。贴壁或乳头成分的存在和腺泡或实体成分的不存在与肺腺癌中 EGFR 突变的比例增加显著相关。
在 p 期 I 期浸润性肺腺癌患者中,不仅要使用主要亚型,而且要根据我们的分类分析每个组织学成分的程度,以预测患者的预后并制定合适的术后随访方法,这是有益的。